These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34813346)

  • 1. Letter by Romero-Jiménez et al Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia".
    Romero-Jiménez MJ; Castaño MÁ; Mansilla ME; Mata P
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):e524-e525. PubMed ID: 34813346
    [No Abstract]   [Full Text] [Related]  

  • 2. Response by Paquette and Baass to Letter Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia".
    Paquette M; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):e526-e527. PubMed ID: 34813347
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?
    Brunham LR; Mancini GBJ
    Trends Cardiovasc Med; 2021 May; 31(4):216-217. PubMed ID: 32407995
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
    Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013.
    Mundal L; Igland J; Ose L; Holven KB; Veierød MB; Leren TP; Retterstøl K
    Eur J Prev Cardiol; 2017 Jan; 24(2):137-144. PubMed ID: 27794106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):815-816. PubMed ID: 35157033
    [No Abstract]   [Full Text] [Related]  

  • 10. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
    Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
    Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
    Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in gauging atherosclerotic cardiovascular disease risk heterogeneity in familial hypercholesterolemia.
    Mizuta MH; Santos RD
    Atherosclerosis; 2022 Oct; 358():57-59. PubMed ID: 36049962
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Natale F; Di Maio M; Calabrò P
    Circulation; 2017 Nov; 136(20):1982-1983. PubMed ID: 29133533
    [No Abstract]   [Full Text] [Related]  

  • 17. [First Brazilian Guidelines for Familial Hypercholesterolemia].
    Santos RD; Gagliardi AC; Xavier HT; Casella Filho A; Araújo DB; Cesena FY; Alves RJ; ; Pereira AC; Lottemberg AM; Chacra AP; Faludi AA; Sposito AC; Ribeiro Filho FF; Helfenstein Fonseca FA; de Carlos Back Giuliano I; Catani LH; Bertolami MC; Hiroshi Miname M; Izar MC; Monte O; Maranhão RC; Martinez TL; Arruda Machado V; Zorzanelli Rocha V; Salgado Filho W;
    Arq Bras Cardiol; 2012 Aug; 99(2 Suppl 2):1-28. PubMed ID: 23532256
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Tromp et al Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Tromp TR; Hovingh GK; Reeskamp LF
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e44-e45. PubMed ID: 34936472
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial hypercholesterolemia.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K; Harada-Shiba M; Arai H; Bujo H; Nohara A; Ohta T; Oikawa S; Okada T; Wakatsuki A
    J Atheroscler Thromb; 2014; 21(1):6-10. PubMed ID: 24335046
    [No Abstract]   [Full Text] [Related]  

  • 20. Response by Björnsson et al to Letter Regarding Article, "Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland".
    Björnsson E; Thorgeirsson G; Helgadóttir A; Gudbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e46-e47. PubMed ID: 34936471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.